Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110320013 | 11032001 | 3 | F | 2000 | 20160714 | 20150415 | 20160721 | EXP | US-009507513-1504USA010422 | MERCK | 0.00 | M | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110320013 | 11032001 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 110320013 | 11032001 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110320013 | 11032001 | 1 | Alopecia |
| 110320013 | 11032001 | 2 | Thyroid disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110320013 | 11032001 | HO |
| 110320013 | 11032001 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110320013 | 11032001 | Asthenia | |
| 110320013 | 11032001 | Brain injury | |
| 110320013 | 11032001 | Ejaculation disorder | |
| 110320013 | 11032001 | Endocrine disorder | |
| 110320013 | 11032001 | Erectile dysfunction | |
| 110320013 | 11032001 | Exercise tolerance decreased | |
| 110320013 | 11032001 | Hypogonadism | |
| 110320013 | 11032001 | Knee operation | |
| 110320013 | 11032001 | Libido decreased | |
| 110320013 | 11032001 | Muscle mass | |
| 110320013 | 11032001 | Painful ejaculation | |
| 110320013 | 11032001 | Penile size reduced | |
| 110320013 | 11032001 | Penis injury | |
| 110320013 | 11032001 | Prostatic specific antigen increased | |
| 110320013 | 11032001 | Sexual dysfunction | |
| 110320013 | 11032001 | Testicular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110320013 | 11032001 | 1 | 2000 | 2008 | 0 | |
| 110320013 | 11032001 | 2 | 1995 | 0 |